Check-Cap Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHEK research report →
About the company
Check-Cap Ltd. is an Israeli medical diagnostics company currently in the clinical development phase. It is dedicated to advancing a novel capsule-based screening method that employs ultra-low-dose X-rays.
- CEO
- David Lontini
- IPO
- 2015
- Employees
- 85
- HQ
- Isfiya, IL
Price Chart
- Market Cap
- $10.88M
- P/E
- 1.73
- P/S
- 0.00
- P/B
- 2.07
- EV/EBITDA
- 1.53
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 416.71%
- ROIC
- -68.72%
- Revenue
- $0 · 0.00%
- Net Income
- $-25,149,000 · -43.15%
- EPS
- $-4.30 · -43.33%
- Op Income
- $-25,949,000
- FCF YoY
- 99.95%
- 52W High
- $3.13
- 52W Low
- $0.56
- 50D MA
- $1.72
- 200D MA
- $1.08
- Beta
- 0.46
- Avg Volume
- 2.99M
Get TickerSpark's AI analysis on CHEK
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CHEK coverage
Recent articles, reports, and earnings notes.
No research on CHEK yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CHEK report →Similar companies
Peers in the same neighborhood.